选择性分子通道阻塞可以防止心房动
Guy Amit1, Kan Kikuchi, Ian D Greener
1Heart and Vascular Research Center, MetroHealth Hospital, Case Western Reserve University, Cleveland, OH 44109, USA.
Circulation
|May 19, 2010
概括
使用KCNH2-G628S的基因疗法通过延长心房动作潜力,成功地预防了猪的心房动 (AF). 然而,这种治疗效果是短暂的,与转基因表达水平相关.
科学领域:
- 心血管研究研究心血管研究
- 基因治疗 基因治疗
- 电子生理学 电子生理学
背景情况:
- 目前的心房 (AF) 疗法在安全性和有效性方面存在局限性.
- AF通常是由重新进入机制驱动的.
- 通过基因转移准心房电生理学提供了一种新的治疗方法.
研究的目的:
- 通过操纵心房电生理学来研究心房基因转移的潜力,以预防AF.
- 评估I(Kr) 通道子单元 (KCNH2-G628S) 的主导阴性突变在预防AF方面的有效性.
主要方法:
- 在猪AF模型中,KCNH2-G628S的腺病毒介导的心脏上心房基因转移.
- 评估心律,电生理学和移植后的分子变化.
- 对照动物和接受KCNH2-G628S基因转移的动物之间的比较.
主要成果:
- 接受KCNH2-G628S基因转移的动物显示,AF的相对风险显著降低 (0.44,P<0.01).
- 在G628S动物中,心房动作潜力的持续时间延长,KCNH2蛋白水平增加.
- 治疗疗效和作用潜力的延长在术后21天减少,与减少的基因表达相关.
结论:
- 使用KCNH2-G628S的基因治疗有效地通过延长心房动作潜力的持续时间来消除AF.
- 治疗效果的持续时间与转基因表达的持续时间直接相关.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...


